Meeting
2020 ASCO Virtual Scientific Program
Characterization of NRG1 gene fusion events in solid tumors.
Authors
Sushma Jonna
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
Sushma Jonna , Rebecca Feldman , Sai-Hong Ignatius Ou , Misako Nagasaka , Jeffrey Swensen , Wolfgang Michael Korn , Hossein Borghaei , Ari M. Vanderwalde , Gilberto Lopes , Jorge J. Nieva , Alexander I. Spira , Edward S. Kim , Stephen V. Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
New Targets and New Technologies (IO)
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3113)
DOI
10.1200/JCO.2020.38.15_suppl.3113
Abstract #
3113
Poster Bd #
177
Abstract Disclosures
Similar Posters
First Author: Brinda Gupta
Poster
2019 ASCO Annual Meeting
Clinicopathologic characteristics of NRG1 fusion-positive cancers: A single-institution study.
First Author: Alison M. Schram
Poster
2019 ASCO Annual Meeting
NRG1 fusion-positive lung cancers: Clinicopathologic profile and treatment outcomes from a global multicenter registry.
First Author: Michaël Duruisseaux
First Author: Stephen V. Liu